SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Morgan Stanley India Investment Fund, Inc. (IIF) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 58/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — IIF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio10.41
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.65
Book Value / Share$0.00
Revenue / Share$2.18
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.34 |
$4.93M |
$19.36M |
393.1% |
| 2017 |
$12.96 |
$187.33M |
$185.81M |
99.2% |
| 2018 |
$-7.87 |
$-109.67M |
$-110.56M |
- |
| 2019 |
$-0.18 |
$-1.86M |
$-2.42M |
- |
| 2020 |
$1.14 |
$13.55M |
$12.87M |
95% |
| 2021 |
$7.29 |
$82.42M |
$81.83M |
99.3% |
| 2022 |
$-3.30 |
$-35.56M |
$-36.25M |
- |
| 2023 |
$4.96 |
$2.14M |
$49.29M |
2303.2% |
| 2024 |
$6.46 |
$1.97M |
$62.43M |
3162.4% |
| 2025 |
$-0.65 |
$20.56M |
$-6.12M |
-29.8% |
